In individuals affected by familial forms of pulmonary arterial hypertension (PAHF) associated with loss-of-function mutations in bone morphogenetic protein receptor type II (BMPR2), a major genetic cause of PAHF, TNC overexpression is evident in pulmonary vascular lesions. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.